Faculty

Diana Buist

Affiliate Professor, Epidemiology

206-287-2931
Diana.S.Buist@kp.org

Education

PhD Epidemiology, University of Washington, 1999
MPH Epidemiology, Yale University, 1995

Contact

206-287-2931
Diana.S.Buist@kp.org

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Bio

Diana Buist, PhD, MPH, is an epidemiologist and health services researcher with extensive experience conducting comparative effectiveness research. Her work focuses on reducing harms and increasing benefits for patients in the area of cancer screening and outcomes spanning across patient, provider, and system factors.

Dr. Buist has an extensive record of practical research that has led to many efforts to improve care, including the development and refinement of national breast cancer screening guidelines. She has been conducting research within Kaiser Permanente Washington for more than 20 years and is a strong believer in patient-centered care and the important role patients play in improving the value and quality of health care.

Research Areas

Research Interests

  • Comparative effectiveness research
  • Delivery system science
  • Learning health care system research
  • Dissemination and implementation
  • Pragmatic clinical trials
  • Epidemiology
  • Health services

Recent Publications (PubMed)

The influence of treatment on hormone receptor subgroups and breast cancer-specific mortality within US integrated healthcare systems.
(2022 May 18)
Cancer Causes Control
Ramin C, Gierach GL, Abubakar M, Veiga LHS, Vo JB, Curtis RE, Bowles EJ, Feigelson HS, Buist DSM, de Gonzalez AB, Bodelon C
Imaging Surveillance Options for Individuals With a Personal History of Breast Cancer: AJR Expert Panel Narrative Review.
(2022 May 11)
AJR Am J Roentgenol
Lawson MB, Herschorn SD, Sprague BL, Buist DSM, Lee SJ, Newell MS, Lourenco AP, Lee JM
Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification.
(2022 May)
J Am Coll Radiol 19(5): 615-624
Smith RE, Sprague B, Henderson LM, Kerlikowske K, Miglioretti DL, Buist DSM, Wernli KJ, Onega T, Schifferdecker K, Jackson-Nefertiti G, Johnson D, Budesky J, Tosteson ANA
Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016.
(2022 May)
Breast Cancer Res Treat 193(1): 203-216
Bowles EJA, Ramin C, Buist DSM, Feigelson HS, Weinmann S, Veiga LHS, Bodelon C, Curtis RE, Vo JB, Berrington de Gonzalez A, Gierach GL
Independent External Validation of Artificial Intelligence Algorithms for Automated Interpretation of Screening Mammography: A Systematic Review.
(2022 Feb)
J Am Coll Radiol 19(2 Pt A): 259-273
Anderson AW, Marinovich ML, Houssami N, Lowry KP, Elmore JG, Buist DSM, Hofvind S, Lee CI
Show complete publication list